SARS-CoV-2 responsive T cell numbers are associated with protection from COVID-19: A prospective cohort study in keyworkers
WYLLIE, D. H.; Mulchandani, R.; Jones, H. E.; Taylor-Phillips, S.; Brooks, T.; Charlett, A.; Ades, A.; Study Investigators, E.-H.; Makin, A.; Oliver, I.
10.1101/2020.11.02.20222778 medRxivShow abstract
Immune correlates of protection from COVID-19 are incompletely understood. 2,826 keyworkers had T-SPOT(R) Discovery SARS-CoV-2 tests (measuring interferon-{gamma} secreting, SARS-CoV-2 responsive T cells, Oxford Immunotec Ltd), and anti-Spike S1 domain IgG antibody levels (EuroImmun AG) performed on recruitment into a cohort study. 285/2,826 (10.1%) of participants had positive SARS-CoV-2 RT-PCR tests, predominantly associated with symptomatic illness, during 200 days followup. T cell responses to Spike, Nucleoprotein and Matrix proteins (SNM responses) were detected in some participants at recruitment, as were anti-Spike S1 IgG antibodies; higher levels of both were associated with protection from subsequent SARS-CoV-2 test positivity. In volunteers with moderate antibody responses, who represented 39% (252/654) of those with detectable anti-Spike IgG, protection was partial, and higher with higher circulating T cell SNM responses. SARS-CoV-2 responsive T cell numbers predict protection in individuals with low anti-Spike IgG responses; serology alone underestimates the proportion of the population protected after infection.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Anti-spike antibody response to natural SARS-CoV-2 infection in the general population 96%
- Seven-month kinetics of SARS-CoV-2 antibodies and protective role of pre-existing antibodies to seasonal human coronaviruses on COVID-19 95%
- Typically asymptomatic but with robust antibody formation: Children’s unique humoral immune response to SARS-CoV-2 95%
Similar papers in this journal
- Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors 94%
- Seroconversion stages COVID19 into distinct pathophysiological states 93%
- Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein after infection and/or vaccination 93%
Similar papers in this journal
- Initial antigen encounter determines robust T-cell immunity against SARS-CoV-2 BA.2.86 variant three years later 94%
- Effectiveness of BNT162b2 mRNA vaccine third doses and previous infection in protecting against SARS-CoV-2 infections during the Delta and Omicron variant waves; the UK SIREN cohort study September 2021 to February 2022 93%
- Inconsistent directions of change in case severity across successive SARS-CoV-2 variant waves suggests an unpredictable future 93%
Similar papers in this journal
- SARS-CoV-2 infectivity by viral load, S gene variants and demographic factors and the utility of lateral flow devices to prevent transmission 94%
- The duration, dynamics and determinants of SARS-CoV-2 antibody responses in individual healthcare workers 94%
- Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom 94%
Similar papers in this journal
- Characterising heterogeneity and sero-reversion in antibody responses to mild SARS⍰CoV-2 infection: a cohort study using time series analysis and mechanistic modelling 97%
- Anti-SARS-CoV-2 Antibodies Persist for up to 13 Months and Reduce Risk of Reinfection 95%
- Follow-up study in the ski-resort Ischgl: Antibody and T cell responses to SARS-CoV-2 persisted for up to 8 months after infection and transmission of virus was low even during the second infection wave in Austria 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.